Comparison of Clinical Outcome and Cost-Effectiveness after Various Preoperative Biliary Drainage Methods in Periampullary Cancer with Obstructive Jaundice by Hong, Suk Kyun et al.
© 2012 The Korean Academy of Medical Sciences.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) 
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
pISSN 1011-8934
eISSN 1598-6357
Comparison of Clinical Outcome and Cost-Effectiveness after 
Various Preoperative Biliary Drainage Methods in Periampullary 
Cancer with Obstructive Jaundice
The aim of this study was to compare the clinical outcome and cost-effectiveness of 
preoperative biliary drainage (BD) methods in periampullary cancer, and to suggest 
guidelines for selecting the appropriate preoperative BD method. Between October 2004 
and August 2010, 211 patients underwent pancreatoduodenectomy after preoperative BD. 
Clinical outcome and cost-effectiveness of the preoperative BD methods were compared 
based on the final drainage method used and on intention-to-treat analysis. There was no 
significant difference in drainage duration between percutaneous transhepatic biliary 
drainage (PTBD) and endoscopic BD groups (14.2 vs 16.6 days, respectively; P = 0.121) but 
daily diminution of serum bilirubin level was higher in the PTBD group (0.7 vs 0.6 mg/dL/
day, respectively; P = 0.041). Based on intention-to-treat analysis, drainage duration was 
shorter (13.2 vs 16.5 days, respectively; P = 0.049), daily diminution of serum bilirubin 
level was higher (0.7 vs 0.6 mg/dL/day, respectively; P = 0.041). Medical care cost was 
lower (14.2 vs 15.7 × 10
3 USD, respectively; P = 0.040) in the PTBD group than in the 
endoscopic BD group. When selecting the preoperative BD method, practitioners should 
consider that PTBD is more cost-effective and safer than endoscopic BD.
Key Words: Drainage; Biliary Cancer; Jaundice; Preoperative; Pancreatoduodenectomy
Suk Kyun Hong, Jin-Young Jang,  
Mee Joo Kang, In Woong Han,  
and Sun-Whe Kim
Department of Surgery & Cancer Research Institute, 
Seoul National University College of Medicine, 
Seoul, Korea
Received: 15 September 2011
Accepted: 20 January 2012
Address for Correspondence:
Jin-Young Jang, MD
Department of Surgery, Seoul National University College of 
Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea
Tel: +82.2-2072-2194, Fax: +82.2-745-2282 
E-mail: jangjy4@snu.ac.kr
This study is supported by a grant from Yonkang Foundation, 
Seoul, Republic of Korea (No. 30-2009-002-0) and the National 
R&D Program for Cancer Control, Ministry of Health &
Welfare, Republic of Korea (No. 1120310).
http://dx.doi.org/10.3346/jkms.2012.27.4.356  •  J Korean Med Sci 2012; 27: 356-362
ORIGINAL ARTICLE
Oncology & Hematology
INTRODUCTION
The clinical benefit of preoperative biliary drainage (BD) in peri-
ampullary cancer with obstructive jaundice is not well estab-
lished (1-7). However, preoperative BD is still performed in many 
cases, for example, when planning preoperative chemoradio-
therapy, for preoperative risk evaluation, in preexisting cholan-
gitis or liver function abnormality, for severe malnutrition, and 
when expecting long waiting times for surgery due to insuffi-
cient admission beds (8, 9).
  Drainage can be accomplished either externally through per-
cutaneous transhepatic biliary drainage (PTBD) or internally 
through endoscopic naso-biliary drainage (ENBD) or endoscop-
ic retrograde biliary drainage (ERBD). PTBD makes preopera-
tive cholangiography possible and it can be left in place after an 
operation. It also makes postoperative decompression and chol-
angiography possible (10, 11). However, cholangitis, bile perito-
nitis due to bile leakage, bleeding, pain at insertion site, tube 
dysfunction, body fluid loss with electrolyte imbalance are also 
possible (3, 10-12). On the other hand, both diagnosis and inter-
vention are possible when using ENBD and ERBD. These two 
endoscopic methods have been experimentally shown to have 
beneficial effects on restoring nutritional status and immune 
function and reducing endotoxemia (8, 15). However, reflux of 
duodenal contents may result in cholangitis or pancreatitis. Du-
odenal perforation, bleeding, and tube dysfunction may also be 
possible when using endoscopic BD (8-11, 13).
  To our knowledge, there are few studies comparing these BD 
methods (14, 15). In the absence of strong evidence, selection 
of a preoperative BD method in a clinical situation depends on 
clinician’s or hospital facility’s preferences. The aims of this study 
were to compare the clinical outcome and cost-effectiveness of 
these preoperative BD methods in periampullary cancer, con-
sidering the final drainage method used and by using intention-
to-treat analysis, and to suggest guidelines for selecting an ap-
propriate preoperative BD method.
MATERIALS AND METHODS
Clinicopathologic data were prospectively collected in electron-
ic medical record form and retrospectively reviewed. A consec-
utive series of 343 patients who underwent preoperative BD at 
Seoul National University Hospital, for periampullary cancer 
with obstructive jaundice, between October 2004 and August Hong SK, et al.  •  Preoperative Biliary Drainage Methods in Periampullary Cancer 
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2010 were included. Preoperative BD was performed when the 
patient had cholangitis or poor liver function, or when patho-
logic confirmation or recovery of general condition was needed 
in patients with severe comorbidity. Surgery was performed af-
ter management for underlying cardiovascular or pulmonary 
diseases was completed and two weeks after improvement of 
cholangitis and restoration of liver function tests. Of the 343 pa-
tients, 55 were excluded because they underwent operations 
other than pancreatoduodenectomy, and 77 patients with BD 
previously performed at other hospitals were also excluded. As 
a result, 211 patients were included in this study. The preopera-
tive BD methods were PTBD, ENBD, and ERBD. The ENBD and 
ERBD patients were considered as a single endoscopic BD group. 
Tumor locations were the ampulla of Vater, distal common bile 
duct (CBD), pancreas, and duodenum. Operation types were 
Whipple’s operation and pylorus preserving pancreatoduode-
nectomy (PPPD). Daily diminution of serum bilirubin was cal-
culated using the initial and final, preoperative serum bilirubin 
levels and the drainage duration. The definitions of all compli-
cations, as well as of their management, were evaluated accord-
ing to generally accepted criteria (16-19). We estimated the pa-
tient’s total hospital cost by adding up all associated costs from 
the day the patient visited for diagnosing and performing pre-
operative BD to the day the patient was discharged following 
performance of the pancreatoduodenectomy.
  Thirty-nine patients who were initially subjected to endo-
scopic BD were switched to PTBD due to a procedure failure or 
an ineffective endoscopic BD. Therefore, clinical outcome and 
cost-effectiveness of each preoperative biliary drainage meth-
ods were compared on the basis of the final drainage method 
that was used and on results of intention-to-treat analysis.
  Results are expressed as means and ranges or as the number 
and percentage of patients. The software program SPSS for Win-
dows (version 19.0; SPSS Inc., Chicago, IL, USA) was used for all 
statistical analyses. One-way analysis of variance was used to 
compare means of continuous variables. Univariate compari-
sons for all categorical variables were performed by using the 
chi-square test or Fisher’s exact test, as appropriate. A probabil-
ity (P) value  ≤ 0.05 was considered significant.
Ethics statement
This study was approved by the institutional review board of 
Seoul National University Hospital (IRB No.H-1001-047-307). 
Informed consent was exempted by the board for this was a ret-
rospective study of prospectively collected data.
RESULTS
Patient demographics
There were 211 patients who underwent pancreatoduodenec-
tomy at our hospital between October 2004 and August 2010. 
Of those, 136 patients (64.5%) were male and 75 (35.5%) were 
female. The mean age was 64.8 yr (range 35-89). Of the total, 191 
patients (90.5%) underwent PPPD and 20 (9.5%) underwent 
Whipple’s operation. Forty-seven patients (22.3%) had adeno-
carcinoma of the ampulla of Vater, 80 (37.9%) had adenocarci-
noma of the distal CBD, 78 (37.0%) had adenocarcinoma of the 
pancreas, and 6 (2.8%) had adenocarcinoma of the duodenum. 
Eighty-one patients (38.4%) had cholangitis before the preop-
erative BD procedure. Based on the TNM staging system, 141 
patients (66.8%) were T3 and 99 (46.9%) were node positive 
(Table 1).
  Based on the patient’s final BD status, 107 patients (50.7%) 
underwent PTBD, 53 (25.1%) underwent ERBD, and 51 (24.2%) 
underwent ENBD. Considering tumor location, PTBD was more 
frequently performed than endoscopic BD in pancreas cancer 
(43.9% vs 29.8%) while endoscopic BD was more frequently per-
formed than PTBD in distal CBD or ampulla of Vater cancer 
(70.2% vs 50.4%) (P = 0.001). PPPD was more frequently per-
formed than Whipple’s operation in both BD groups. There were 
no significant differences in operation time, intraoperative blood 
loss, T stage, and N stage between the PTBD and endoscopic 
BD groups (Table 2).
  Thirty-nine patients (18.5%) who initially underwent endo-
scopic BD were switched to PTBD due to procedure failure (n =  
37, 94.9%) or ineffective endoscopic BD (n = 2, 5.1%). On an in-
tention-to-treat basis, 68 patients (32.2%) underwent intention-
al PTBD and 143 patients (67.8%) underwent intentioned endo-
scopic BD. Intentioned PTBD was more frequently performed 
Table 1. Clinicopathologic chacteristics of overall patients
Variables  Total (n = 211) 
Age (mean ± SD, yr)  64.8 ± 8.9 
Sex (M:F)  136:75 
Tumor location 
   AoV
   Distal CBD 
   Pancreas 
   Duodenum 
 
  47 (22.3%) 
  80 (37.9%) 
  78 (37.0%)
  6 (2.8%)
Type of operation 
   Whipple’s operation
   PPPD 
20 (9.5%)
191 (90.5%)
Operation time (mean ± SD, min) 339.3 ± 82.5
Estimated blood loss (mean ± SD, mL)   482.7 ± 477.4
T stage
   T1
   T2
   T3
   T4
 
18 (8.5%)
  40 (19.0%)
141 (66.8%)
12 (5.7%)
N stage
   N0
   N1
 
112 (53.1%)
  99 (46.9%)
M stage
   M0
   M1
 
208 (98.6%)
  3 (1.4%)
AoV, ampulla of Vater; CBD, common bile duct; PPPD, pylorus preserving pancreato-
duodenectomy.Hong SK, et al.  •  Preoperative Biliary Drainage Methods in Periampullary Cancer 
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than intentioned endoscopic BD in pancreas cancer (47.1% vs 
32.2%) while intentioned endoscopic BD was more frequently 
performed than intentioned PTBD in distal CBD (30.9% vs 41.3%) 
or ampulla of Vater cancer (16.2% vs 25.2%) (P = 0.029). There 
was no significant difference in operation time, intraoperative 
blood loss, T stage, and N stage between the intentioned PTBD 
and intentioned endoscopic BD groups (Table 3).
 
Effectiveness of biliary decompression
Overall the initial serum bilirubin level was 11.2 ± 6.9 mg/dL, 
and the final serum bilirubin level was 3.7 ± 3.3 mg/dL, and 
mean BD duration was 15.4 ± 11.2 days. There was no signifi-
cant difference in drainage duration between PTBD and endo-
scopic BD groups (14.2 vs 16.6 days, respectively; P = 0.121); 
however, daily diminution of serum bilirubin level was higher 
in the PTBD group (0.7 vs 0.6 mg/dL/day, respectively; P = 0.041) 
(Table 4). Within the endoscopic BD group, the ERBD subgroup 
had a longer drainage duration than the ENBD subgroup (19.0 
vs 14.1 days, respectively; P = 0.029), but daily diminution of se-
rum bilirubin was comparable between the two groups (0.5 vs 
0.6 mg/dL/day, respectively; P = 0.339) (Table 5, Fig. 1).
  On an intention-to-treat basis, drainage duration was shorter 
(13.2 vs 16.5 days, respectively; P = 0.049) and daily diminution 
of serum bilirubin level was higher (0.7 vs 0.6 mg/dL/day, respec-
tively; P = 0.041) in the intentioned PTBD group than in the in-
tentioned endoscopic BD group (Table 4).
Procedure related and postoperative complications
Procedure-related complications are outlined in Table 6. One 
or more complications occurred in 62 of the patients in the study 
(29.4%). Among the 6 PTBD patients (5.6%) with a bleeding 
complication, 3 underwent gelfoam embolization without fur-
ther complication. Pancreatitis occurred more frequently in the 
endoscopic BD group than in the PTBD group (16.3% vs 2.8%, 
respectively; P = 0.001). Two of the pancreatitis patients in the 
endoscopic BD group had to wait for surgery for two weeks in 
order to treat their pancreatitis before surgery. Thirty-nine pa-
tients who were initially subjected to endoscopic PBD were 
Table 2. Comparision of clinicopathologic characteristics according to final biliary 
drainage methods
Parameters
PTBD  
(n = 107)
ERBD or ENBD  
(n = 104)
P value
Age (mean ± SD, yr) 63.5 ± 9.0 66.3 ± 8.6 0.022
Sex (M:F) 65:42 71:33 0.254
Tumor location
   AoV
   Distal CBD
   Pancreas
   Duodenum
 
18 (16.8%)
36 (33.6%)
47 (43.9%)
6 (5.6%)
 
29 (27.9%)
44 (42.3%)
31 (29.8%)
0
0.001
Preoperative cholangitis 42 (39.3%) 39 (37.5%) 0.794
Type of operation
   Whipple’s operation
   PPPD
 
15 (14.0%)
92 (86.0%)
 
5 (4.8%)
99 (95.2%)
0.022
Operation time 
   (mean ± SD, min)
347.7 ± 80.6 330.8 ± 83.8 0.139
Estimated blood loss 
   (mean ± SD, mL)
  498.2 ± 522.9   466.9 ± 428.1 0.651
T stage
   T1,2
   T3,4
 
25 (23.4%)
82 (76.6%)
 
33 (31.7%)
71 (68.3%)
0.276
Lymph node metastasis 53 (49.5%) 46 (44.2%) 0.440
PTBD, percutaneous transhepatic biliary drainage; ERBD, endoscopic retrograde bili-
ary drainage; ENBD, endoscopic naso-biliary drainage; AoV, ampulla of Vater; CBD, 
common bile duct; PPPD, pylorus preserving pancreatoduodenectomy.
Table 3. Comparision of cilinicopathologic characteristics according to biliary drain-
age methods after intention-to-treat analysis
Parameters
Intentioned  
PTBD (n = 68)
Intentioned  
ERBD/ENBD
(n = 143)
P value
Age (mean ± SD, yr)  63.5 ± 9.0 65.5 ± 8.7 0.128
Sex (M:F)  33:35 103:40 0.001
Tumor location 
   AoV
   Distal CBD 
   Pancreas 
   Duodenum 
 
11 (16.2%)
21 (30.9%)
32 (47.1%)
4 (5.9%)
 
   36 (25.2%)
   59 (41.3%)
   46 (32.2%)
   2 (1.4%)
0.029
Preoperative cholangitis  26 (38.2%)    55 (38.5%) 0.975
Type of operation 
   Whipple 
   PPPD 
  
10 (14.7%)
58 (85.3%)
 
 10 (7.0%)
 133 (93.0%)
0.074
Operation time  
   (mean ± SD, min)
343.1 ± 78.6 337.5 ± 84.4 0.642
Estimated blood loss 
   (mean ± SD, mL)
  488.4 ± 444.0   480.0 ± 494.1 0.910
T stage 
   T1,2 
   T3,4 
  
16 (24.2%)
50 (75.8%)
  
   40 (28.0%)
 103 (72.0%)
0.571
Lymph node metastasis 33 (50.0%) 33 (50%) 0.540
PTBD, percutaneous transhepatic biliary drainage; ERBD, endoscopic retrograde bili-
ary drainage; ENBD, endoscopic naso-biliary drainage; AoV, ampulla of Vater; CBD, 
common bile duct; PPPD, pylorus preserving pancreatoduodenectomy.
Table 4. Effectiveness of biliary decompression 
Parameters
Final drainage Intention-to-treat
  PTBD  
  (n = 107)
ERBD/ENBD  
(n = 104)
P value
  PTBD  
  (n = 68)
ERBD/ENBD  
(n = 143)
P value
Initial bilirubin (mg/dL) 12.1 ± 6.7 10.3 ± 7.1 0.068 11.1 ± 6.2 11.2 ± 7.3 0.884
Final bilirubin (mg/dL)   4.4 ± 3.4   3.0 ± 3.0 0.002   4.0 ± 3.1   3.6 ± 3.4 0.370
Daily diminution of bilirubin ([mg/dL]/day)   0.7 ± 0.5   0.6 ± 0.4 0.049   0.7 ± 0.5   0.6 ± 0.4 0.041
Drainage duration (day)   14.2 ± 10.9   16.6 ± 11.5 0.121   13.2 ± 11.5   16.5 ± 11.0 0.049
PTBD, percutaneous transhepatic biliary drainage; ERBD, endoscopic retrograde biliary drainage; ENBD, endoscopic naso-biliary drainage.Hong SK, et al.  •  Preoperative Biliary Drainage Methods in Periampullary Cancer 
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switched to PTBD due to procedure failure (94.9%) or ineffec-
tive BD (5.1%).
  On an intention-to-treat basis, bleeding (8.8% vs 2.1%, respec-
tively; P = 0.024) and bile peritonitis (2.9% vs 0%, respectively; 
P = 0.039) occurred more often in the intentioned PTBD group 
than in the intentioned endoscopic BD group. Pancreatitis oc-
curred more frequently in intentioned endoscopic BD group 
than in the PTBD group (0% vs 14.0%, respectively; P = 0.001) 
(Table 6).
  The overall postoperative complication rate was comparable 
between the PTBD and endoscopic BD groups (39.3% vs 47.1%, 
respectively; P = 0.155). On an intention-to-treat basis, there 
was no significant difference in postoperative complication rate 
between the intentioned PTBD group and the intentioned en-
doscopic BD group (Table 7).
Comparison of cost-effectiveness
There was no significant difference in total hospital cost, admis-
sion cost, hospital stay duration between the PTBD and endo-
scopic BD groups. On an intention-to-treat basis, there was no 
significant difference in total hospital cost and hospital stay du-
ration, but admission cost was significantly lower in the inten-
tioned PTBD group than in the intentioned endoscopic BD 
group (14.2 ± 3.9 × 10
3 USD vs 15.7 ± 7.0 × 10
3 USD, respective-
ly; P = 0.040) (Table 8).
Table 6. Procedure-related complications of each biliary drainage methods
Complications
Final drainage Intention-to-treat
  PTBD  
  (n = 107)
ERBD/ENBD  
(n = 104)
P value
  PTBD  
  (n = 68)
ERBD/ENBD  
(n = 143)
P value
Bleeding    6 (5.6%) 3 (2.9%) 0.499 6 (8.8%)   3 (2.1%) 0.024
Pancreatitis    3 (2.8%) 17 (16.3%) 0.001 0   20 (14.0%) 0.001
Cholangitis    9 (8.4%) 5 (4.8%) 0.293   7 (10.3%)   16 (11.2%) 0.845
Malfunction    9 (8.4%) 7 (6.7%) 0.645 4 (5.9%) 12 (8.4%) 0.520
Bile peritonitis    2 (1.9%) 0 0.498 2 (2.9%) 0 0.039
Repeated procedures  10 (9.3%) 14 (13.5%) 0.347   8 (11.8%)   16 (11.2%) 0.902
Total    33 (30.8%) 29 (27.9%) 0.637 17 (25.0%)   45 (31.5%) 0.335
PTBD, percutaneous transhepatic biliary drainage; ERBD, endoscopic retrograde biliary drainage; ENBD, endoscopic naso-biliary drainage.
Table 7. Postoperative complications
Complications
Final drainage Intention-to-treat
 PTBD  
 (n = 107)
ERBD/ENBD  
(n = 104)
P value
 PTBD  
 (n = 68)
ERBD/ENBD  
(n = 143)
P value
Bleeding  2 (1.9%) 2 (1.9%) 0.977 1 (1.5%) 3 (2.1%) 0.755
Sepsis 0 2 (1.9%) 0.149 0 2 (1.4%) 0.327
Pancreas fistula  30 (28.0%) 27 (26.0%) 0.734 22 (32.4%) 35 (24.5%) 0.228
Intraabdominal abscess 1 (0.9%) 5 (4.8%) 0.091 0 6 (4.2%) 0.087
Wound problem 11 (10.3%) 11 (10.6%) 0.944   7 (10.3%) 15 (10.5%) 0.965
Bowel obstruction 1 (0.9%) 2 (1.9%) 0.54 1 (1.5%) 2 (1.4%) 0.967
Portal vein thrombosis 1 (0.9%) 0 0.323 0 1 (0.7%) 0.489
Overall 42 (39.3%) 49 (47.1%) 0.155 27 (39.7%) 64 (44.8%) 0.294
PTBD, percutaneous transhepatic biliary drainage; ERBD, endoscopic retrograde biliary drainage; ENBD, endoscopic naso-biliary drainage.
Table 5. Comparison of effectiveness of biliary decompression in endoscopic BD 
method
Parameters
   ERBD  
   (n = 53)
   ENBD  
   (n = 51)
P value
Initial bilirubin (mg/dL) 10.3 ± 7.5 10.3 ± 6.7 0.979
Final bilirubin (mg/dL)   2.2 ± 2.3   3.9 ± 3.4 0.005
Daily diminution of bilirubin 
   ([mg/dL]/day)
  0.5 ± 0.5    0.6 ± 0.4 0.339
Drainage duration (day)   19.0 ± 11.5   14.1 ± 11.2 0.029
ERBD, endoscopic retrograde biliary drainage; ENBD, endoscopic naso-biliary drain-
age.
Fig. 1. A graph of bilirubin decline pattern in the endoscopic BD groups. ERBD, endo-
scopic retrograde biliary drainage; ENBD, endoscopic naso-biliary drainage.
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DISCUSSION
In 4 of 5 randomized trials, preoperative BD by means of PTBD 
was the standard mode of drainage used, whereas endoscopic 
BD is currently preferred in some hospitals, although evidence 
to support this preference is lacking (2, 20, 21). PTBD enables 
preoperative and postoperative biliary decompression and chol-
angiography, but complications such as cholangitis, bile perito-
nitis, bleeding, pain at insertion site, tube dysfunction, and elec-
trolyte imbalance may occur. Endoscopic BD methods make 
both diagnosis and intervention possible, which give chance to 
direct visualization of duodenum and papilla, biopsy for tissue 
diagnosis, and direct cholangiography. However, reflux of duo-
denal contents may result in cholangitis, pancreatitis, duodenal 
perforation, or bleeding. Hwang et al. (22) reported that the thick-
ness and degree of inflammation of the CBD wall was more se-
vere in their endoscopic BD group, and indicated that CBD in-
flammation may have resulted from reflux of duodenal contents. 
There are few comparative studies comparing these BD methods 
(14, 15); therefore, in the absence of strong evidence, selection 
of a preoperative BD method in many cases depends on clini-
cian’s or hospital facility’s preferences.
  In this study, clinical outcome and cost-effectiveness were 
compared between three different preoperative BD methods. 
Considering tumor location, PTBD was more frequently per-
formed than ENBD or ERBD in pancreas cancer, whereas the 
latter two were more frequently performed than PTBD in distal 
CBD or ampulla of Vater cancer, both on a final status basis and 
on an intention-to-treat basis. In distal CBD or ampulla of Vater 
cancer, identification of the lesion and tissue confirmation us-
ing an endoscopic procedure is possible and, on that basis, would 
be preferred to the use of PTBD.
  We evaluated effectiveness by comparing drainage duration 
and daily serum bilirubin decline. On the basis of the final drain-
age method used, there was no difference in drainage duration 
between the PTBD and endoscopic BD groups, but daily dimi-
nution of the serum bilirubin level was higher in the PTBD group. 
The result was similar on an intention-to-treat basis, except for 
drainage duration: the drainage duration was shorter in the in-
tentioned PTBD group than in the intentioned endoscopic BD 
group. Thirty-nine intentioned endoscopic group patients were 
changed to PTBD and the number of days spent between the 
switch is the reason for the difference in drainage duration. Ad-
ditional time is needed to perform PTBD for patients with failed 
endoscopic attempts. In addition, time is needed to determine 
whether the serum bilirubin level declines and, if not, check the 
endoscopic BD function and the perform PTBD. Based on the 
difference in the decreases in bilirubin levels, the effectiveness 
of preoperative BD is better with PTBD than with endoscopic 
BD. However, the optimal duration of BD before surgery has 
not been established. Experimental and clinical studies have 
suggested that a period of at least 4-6 weeks is needed for resto-
ration of normal major synthesis and clearance functions of the 
liver, as well as of mucosal intestinal barrier functions (5). In ad-
dition, depressed cell-mediated immunity, impaired hepatic 
reticuloendothelial function (23), and altered lymphocyte trans-
formation have been documented, and these functions are un-
likely to improve within 4 weeks (24, 25). On the other hand, in-
creasing drainage duration increases the risks of stent clogging 
and secondary inflammatory changes to the bile duct wall. If 
such complications require readmission to a hospital, this might 
lead to surgery postponement (7). However, it is not easy to main-
tain preoperative BD over 4 weeks in a clinical setting. This study 
was not a randomized controlled trial, therefore the preopera-
tive BD method used was selected according to the clinician’s 
preference. However, the time to perform the required opera-
tion after BD was decided consistently as described earlier (i.e. 
following completion of management for underlying cardiovas-
cular or pulmonary diseases and at least two weeks after improve-
ment of cholangitis and restoration of liver function tests).
  With respect to procedure-related complications, the inci-
dences of pancreatitis, cholangitis, bleeding, or malfunction in 
our study was similar to incidences reported by others (26-28). 
There were no significant differences in procedure-related com-
plication rates between the two groups, with the exception of 
procedure-related pancreatitis: the pancreatitis rate was higher 
in the endoscopic BD group than in the PTBD group. Two of 
the pancreatitis cases in the endoscopic BD group prolonged 
the postponement of surgery because medical management of 
the pancreatitis was needed. Such a postponement would be 
unjustifiable for a potentially resectable tumor.
  Cost-effectiveness was evaluated by comparing total hospital 
cost, admission cost, and hospital stay duration. There were no 
significant differences between the two groups on the basis of 
Table 8. Total hospital cost, admission cost, and hospital stay
Cost
Final drainage Intention-to-treat
 PTBD 
 (n = 107)
ERBD/ENBD  
(n = 104)
P value
 PTBD  
 (n = 68)
ERBD/ENBD  
(n = 143)
P value
Total hospital cost (10
3 USD)  16.0 ± 5.9 17.0 ± 7.5 0.299 15.4 ± 6.2 17.0 ± 7.0 0.101
Admission cost (10
3 USD)  14.8 ± 4.7 15.6 ± 7.4 0.362 14.2 ± 3.9 15.7 ± 7.0 0.040
Hospital stay (day)   25.9 ± 35.7   29.4 ± 13.7 0.348   22.8 ± 43.3   30.0 ± 13.9 0.073
PTBD, percutaneous transhepatic biliary drainage; ERBD, endoscopic retrograde biliary drainage; ENBD, endoscopic naso-biliary drainage.Hong SK, et al.  •  Preoperative Biliary Drainage Methods in Periampullary Cancer 
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the final drainage method used; however, on an intention-to-
treat basis, admission cost was lower in the PTBD group than  
in the endoscopic BD group. This could be related to those pa-
tients who were initially subjected to endoscopic BD and who 
were changed to PTBD. There were no significant difference in 
postoperative complication rate between two groups, but the 
cost for managing postoperative complications in the inten-
tioned endoscopic BD group was higher than in the intentioned 
PTBD group. This is in contrast with an earlier randomized study 
in which van der Gaag et al. (29) looked at 202 patients with can-
cer of the pancreatic head. In their multicenter, randomized tri-
al they found no effect of preoperative BD, primarily attempted 
endoscopically, on the length of the hospital stay. They explained 
that the previously observed extended hospital stay durations 
can be attributed to the use of PTBD, whereas endoscopic BD, 
as used primarily in their study, is often performed on an out-
patient basis. In our study, the hospital stay was comparable 
between PTBD and endoscopic BD.
  There are reports of metastatic tumor seeding along the PTBD 
sinus tract (28, 30). Takahashi et al. (28) retrospectively investi-
gated 445 patients with perihilar and distal cholangiocarcinoma 
who underwent resection following PTBD and detected PTBD 
catheter tract recurrence in 23 of those patients. They also re-
ported poor prognosis in PTBD catheter tract recurrence pa-
tients. Moreover, they supported the association of PTBD with 
serious complications, such as vascular injury and cancer dis-
semination, and suggested that ENBD is the most suitable meth-
od for initial preoperative BD. In this study, among 6 PTBD pa-
tients with a bleeding complication, 3 patients underwent gel-
foam embolization without further complication, and there 
was no tract recurrence until the last follow up (median follow 
up of 23 months, range 0.2-46 months). In contrast with their 
study, our study included periampullary lesions but excluded 
hilar cholangiocarcinomas. In Klatskin tumor cases, we believe 
it unlikely that, passing through the tumor during the procedure 
is not needed and can be succeed safely in periampullary can-
cer. However, the only way to answer this question adequately 
would be to conduct a large prospective, randomized trial.
  In conclusion, using an intention-to-treat analysis, the PTBD 
group revealed a more rapid serum bilirubin decline with a short-
er drainage duration and a lower admission cost compared with 
the endoscopic BD group. Although the role of preoperative BD 
is still controversial, preoperative BD is needed in some situa-
tions. The results in this study indicate that PTBD is more cost-
effective and safer than endoscopic BD. Practitioners should 
consider those factors in selecting a BD method. 
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